Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0630-2021Class II

Titanium IFS, Item number 909680 -

Zimmer GmbH / initiated 2020-11-25 / Terminated / root cause: manufacturing process

Biomet, Inc. began a recall of Titanium IFS, Item number 909680 - Product Usage: Bone to bone fixation on . FDA classified it as Class II and gives the reason as "Specific lots of multiple sterile medical devices may have a breach in the sterile seal. A breach in the packaging seal could lead to loss of sterility of the device". As of , the recall status on record is Terminated, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-0630-2021
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Zimmer GmbH
Product
Titanium IFS, Item number 909680 - Product Usage: Bone to bone fixation.
Product code
MBI Fastener, Fixation, Nondegradable, Soft Tissue
Reason for recall
Specific lots of multiple sterile medical devices may have a breach in the sterile seal. A breach in the packaging seal could lead to loss of sterility of the device.
Root cause tag
manufacturing process
FDA root cause
Process control
Action
On November 25, 2020, the firm distributed Urgent Medical Device Recall letters to affected customers. Customers were informed of the potential loss of sterility in affected devices. Customers were asked to do the following: Risk Manager Responsibilities: 1. Review this notification and ensure that affected personnel are aware of the contents. 2. If you have affected product at your facility, assist your Zimmer Biomet sales representative and quarantine all affected product. Your Zimmer Biomet sales representative will remove the affected product from your facility. 3. If the product has been further distributed, provide your customers with the field safety notice for hospitals and ensure documentation. Surgeon Responsibilities: 1. Review this notification for awareness of the contents. 2. There are no specific patient monitoring instructions related to this recall that are recommended beyond your existing follow-up schedule. All customers should also complete the certificate of acknowledgement included with the letter and return to the firm. If you have further questions or concerns after reviewing this notice, please call customer service at 574-371-3071 between 8:00 am and 5:00pm EST, Monday through Friday. Calls received outside of call center operating hours will receive a voicemail prompt or be transferred to an on-call representative in the event of an emergency. Alternatively, your questions may be emailed to [email protected].
Quantity in commerce
7428
Distribution
Worldwide distribution. US nationwide, ARGENTINA, AUSTRALIA, Brazil, CANADA, CHILE, CHINA, COSTA RICA, EMEA, HONG KONG, INDIA, JAPAN, KOREA, MALAYSIA, NEW ZEALAND, SINGAPORE, and TAIWAN
Product codes and lots
Lot 750930

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0630-2021
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0616-2021Class IITerminatedVoluntary: Firm initiated
Z-0617-2021Class IITerminatedVoluntary: Firm initiated
Z-0618-2021Class IITerminatedVoluntary: Firm initiated
Z-0619-2021Class IITerminatedVoluntary: Firm initiated
Z-0620-2021Class IITerminatedVoluntary: Firm initiated
Z-0621-2021Class IITerminatedVoluntary: Firm initiated
Z-0622-2021Class IITerminatedVoluntary: Firm initiated
Z-0623-2021Class IITerminatedVoluntary: Firm initiated
Z-0624-2021Class IITerminatedVoluntary: Firm initiated
Z-0625-2021Class IITerminatedVoluntary: Firm initiated
Z-0626-2021Class IITerminatedVoluntary: Firm initiated
Z-0627-2021Class IITerminatedVoluntary: Firm initiated
Z-0628-2021Class IITerminatedVoluntary: Firm initiated
Z-0629-2021Class IITerminatedVoluntary: Firm initiated
Z-0630-2021Class IITerminatedVoluntary: Firm initiated
Z-0631-2021Class IITerminatedVoluntary: Firm initiated